mouse models with Cre-recombinase expressed in epicardial and/or EPDCs, investigators have demonstrated multiple contributions of EPDCs to coronary smooth muscle, coronary endothelium, the interstitial fibroblast population, and the atrioventricular junctional myocardium.
1,2,7-10
The epicardium plays a pivotal role in cardiac development because paracrine-mediated secretion of epicardial factors, such as Wnts, erythropoietin, fibroblast growth factors, and retinoids, are important for embryonic compact myocardial growth 1, 2 and can be reactivated during cardiac injury and repair. 11 PEO ablation/blockade that perturbs or delays epicardial formation and genetic ablation of various genes expressed in the proepicardium or myocardium leads to abnormal coronary vasculogenesis, myocardial defects, and potential embryonic lethality. 1, 2 T-box transcription factor genes, including Tbx5 and Tbx18, are expressed in the PEO or septum transversum. 1, [12] [13] [14] [15] We previously showed that the manipulation of Tbx5 gene dosage in the chick PEO affects proepicardial cell migration and can impair avian coronary vasculogenesis. 16 However, these studies did not address the potential activity of Tbx5 in the epicardium itself. The mechanisms by which Tbx5 controls mammalian coronary vasculogenesis remain largely unknown, and the relevance of avian signaling to mammalian ontogeny was not tested. Holt-Oram syndrome (HOS) is a human inherited disorder caused by mutations in TBX5 and manifests as congenital cardiac septation and conduction defects in the setting of limb deformities. 17, 18 Some patients with HOS also exhibit left pericardium agenesis and anomalous coronary arteries along with ventricular septal defects 19, 20 consistent with a role for TBX5 in epicardial/pericardial and myocardial development. Early embryonic lethality resulting from germline inactivation of Tbx5 in the mouse has precluded further investigation of the function of Tbx5 in later stages of cardiac development, including epicardial formation and coronary vasculogenesis. 21 We have now developed strategies to investigate epicardial activity of Tbx5 in the chick, and we have generated conditional mutant mice with Tbx5 deletion from the proepicardial and epicardial derivatives. We show that Tbx5 expression in the proepicardium/PEO and epicardium is required for normal development of proepicardium/PEO cells, as well as proper epicardial formation and maturation. Tbx5 deficiency delays epicardial cell attachment to the myocardium, impairs production of EPDCs and their migration into the myocardium, and results in abnormal coronary vasculogenesis and murine ischemic cardiomyopathy. Our findings demonstrate that Tbx5 is required both for proepicardial and for epicardial development in avian and in mammalian hearts and for establishment of the coronary vasculature.
Methods

Tbx5
lox/lox 21 and Wilm's tumor 1 (Wt1)-Cre 8, 22 mice have been described. Generation of retrovirus and in ovo retroviral injection was performed as previously described 16 with the exception of epicardial infection that was accomplished by retroviral injection into the pericardial space of the embryonic chick.
An expanded Methods section, including all experimental procedures, is available in the Online Data Supplement.
Results
Tbx5 Expression in Chick and Mouse PEO and Derivatives
Although Tbx5 myocardial and endocardial expressions have been previously described during cardiogenesis, 16, 23, 24 the detailed spatiotemporal patterns of chick and mouse Tbx5 expression in the PEO/proepicardium and epicardium have not been well defined. In situ hybridization in chick embryos revealed heterogeneous staining in the PEO at HamburgerHamilton (HH) stage 16 or E3 (Online Figure IA and IE) . By HH22 (E4), chick Tbx5 (cTbx5) remained detectable in the PEO remnant and in migrating proepicardial cells contacting the myocardium. By HH26 (E5), cTbx5 was evident in the newly formed epicardium (Online Figure IB and IF) . A similar expression pattern for mouse Tbx5 (mTbx5) was observed by in situ hybridization at the corresponding developmental stages of E9.5 (Online Figure IC and IG) and E10.5 in the mouse (Online Figure ID and IH) . Immunostaining for mTbx5 protein expression showed a spatiotemporal pattern similar to that observed with our in situ hybridization data. At E9.5, nuclear expression of mTbx5 protein was evident in the murine proepicardium in a heterogeneous pattern (Online Figure II and IL). At E10.5, mTbx5 protein expression was evident in the nascent epicardium and pericardium (Online Figure IJ) . Whereas some epicardial cells were Tbx5-negative (online Figure IM) , all epicardial cells expressed Wt1 (Online Figure  IN) . Tbx5 expression was decreased in the epicardial cells by E11.5 (Online Figure IK and IO) , but persists into adulthood as previously shown. 25 Thus, these analyses support spatial and temporal restriction of Tbx5 expression in the embryonic chick and murine PEO/proepicardium and epicardium.
Tbx5 Contributes to In Vitro and In Vivo Proepicardial Cell Development
We previously demonstrated that Tbx5 overexpression disrupts chick proepicardial cell migration in vitro. 16 To determine the requirement for cTbx5 in epicardial formation and coronary vasculogenesis, we used retroviral-mediated transgenesis with an antisense (cTbx5As-CXL) construct (Online Figure IIA) to knock down cTbx5 expression in cultured PEO explants in a manner similar to our previous TBX5 overexpression studies. 16 Retroviral-mediated cTbx5 knockdown produced a 45% reduction of in vitro migration of proepicardial cells to the periphery of PEO explants compared with control CXL PEOs (Online Figure IIIA-IIIC) . This demonstrated that cTbx5 expression is required for in vitro chick proepicardial cell migration.
To confirm that this requirement for cTbx5 was preserved in PEO cell migration and coronary vasculogenesis in vivo, we injected either control CXL 26 or cTbx5As-CXL retrovirus into chick PEOs in ovo at HH17-18 (E3; Online Figure IIA) . By 8 hours after injection, we observed transgene expression in the PEO as shown by X-gal staining for β-galactosidase activity for both retroviruses ( Figure 1A and 1E) . Twentyfour hours after PEO injection with the control CXL virus, β-galactosidase-positive cells were visible on the surface of the heart ( Figure 1B ). However, embryos that received PEO injections of cTbx5As-CXL to knock down Tbx5 expression exhibited only scant β-galactosidase-positive cells on the surface of the heart ( Figure 1F ). By 12 days after injection, E15 CXL-infected embryos (15/15 embryos) displayed prominent β-galactosidase-positive staining in the coronary vasculature ( Figure 1C and 1D) . Hearts from E15 embryos infected with cTbx5As-CXL did not show any evidence of β-galactosidase staining in the coronary vessels (0/13 embryos; Figure 1G ). All hearts exhibited minimal levels of myocardial staining at 24 hours to 12 days after injection because of slight retroviral leakage into the myocardium during the initial pressure injection of the retrovirus as evidenced by β-galactosidase staining of myocardial cells in E15 hearts ( Figure 1C and 1G ). This staining confirmed the infectivity of all viruses. Thus, maintenance of normal Tbx5 expression in the chick PEO is required for proper development of the epicardium and coronary vasculature.
Tbx5 Contributes to Chick Epicardial Cell Fate and Coronary Artery Development
To determine whether Tbx5 activity during coronary vasculogenesis is required in the epicardium independent of its activity in the PEO, we used retroviral-mediated transgenesis to augment or knock down Tbx5 in the nascent epicardium in vivo directly. We microinjected either the same retroviruses as described above or control retrovirus encoding β-galactosidase (CXIZ) and TBX5-CXIZ retrovirus 27 (Online Figure IIA) into the pericardial space (Online Figure IIB) at later stages of development (E4) when the epicardium had largely already formed. This produces transgenesis of the nascent epicardium ( Figure 1I-1P) . Because epicardium formation was not fully completed at this stage, areas of naked myocardium were exposed to viruses with this strategy, and the presence of infected myocardium in each embryo provided a positive control for viral infectivity. β-galactosidasepositive cells demonstrated infectivity of the epicardium at 8 ( Figure 1I epicardium ( Figure 1N and 1P). Thus, maintenance of normal Tbx5 dosage in the epicardium is required for its proper maturation and the subsequent incorporation of EPDCs into coronary blood vessels.
To investigate cellular mechanisms underlying impaired epicardial cell development, we examined the effect of cTbx5 augmentation on in vitro PEO cell behavior. We previously demonstrated that in vitro TBX5 overexpression in PEO explants impaired migration of proepicardial cells out of these TBX5-CXIZ-infected PEO explants but did not affect PEO cell proliferation. 16 In addition to our previous observations, we now detect some apoptotic migratory proepicardial cells outside of the PEO explants (Online Figure IIID-IIIF) . Apoptosis was not observed in control CXIZ-infected migratory proepicardial cells. Thus, in vitro augmentation of proepicardial cTbx5 not only impaired migration of proepicardial cells, but also caused apoptosis in some migratory proepicardial cells.
Epicardial Inactivation of Murine Tbx5 Affects Formation and Maturation of the Epicardium and Migration of EPDCs
In the mouse, ubiquitous deletion of mTbx5 caused embryonic lethality by E10.5 that previously precluded analysis of coronary vasculogenesis. 21 We circumvented this barrier by conditional tissue-specific ablation of Tbx5 in the proepicardium and its derivatives. We crossed C57Bl/6 female Tbx5 conditional knockout mice (Tbx5 lox/lox ) 21 with C57Bl/6 male Wt1-Cre driver mice that express Cre-recombinase in proepicardial and epicardial cells. 8, 22 Male progeny (Tbx5 We analyzed Tbx5 epi-/-embryos at various developmental stages to gain insight into the cause of lethality. Examination of whole mount and sectioned hearts from E9.5 wild-type and mutant mice revealed that both wild-type ( Figure  VE) , and no evidence of increased apoptosis, respectively, in Tbx5 epi-/-proepicardial cells was observed. Furthermore, our examination of proepicardial cell polarity in these embryos did not reveal altered expression or localization of apical (PAR3, ezrin), basolateral (α4-integrin), and cell-cell junctional (ZO-1) markers 28 between wild-type and mutant proepicardiums at E9.5. These data indicated that Tbx5 deficiency did not alter proepicardial cell proliferation, apoptosis, or polarity. The epicardial cell layer, as indicated by Wt1-positive cells, began to form on the myocardial surface of E10.5 wild-type and Tbx5 epi-/-hearts (not shown). Although a smooth-surfaced epicardium was observed in E11.5 wild-type hearts ( Figure 2G and 2H), the epicardium in Tbx5 epi-/-hearts appeared irregular and ruffled with focal regions that were unattached to the myocardium ( Figures 2I and 2J) . However, Wt1-positive epicardial cells were attached to the myocardium in both wildtype ( Figure 3A) and Tbx5 epi-/-( Figure 3D ) hearts by E12.5. These data indicate that deletion of Tbx5 delayed adhesion of the epicardial cell layer to the myocardium, and Tbx5 is important for proper structural formation of the epicardium.
Within the subepicardial space of E13.5 wild-type and mutant hearts, Wt1-positive epicardial cells began to delaminate and EPDCs began invading the compact myocardium ( Figure 3B and 3E). Nonetheless, fewer Wt1-positive EPDCs invaded the compact myocardium of E13.5 mutant hearts ( Figure 3E ). We observed focal accumulation of Wt1-positive cells in the subepicardium of E14.5 mutant embryos ( Figure 3F ) when compared with wild-type littermates ( Figure 3C ). Quantification of these cells in the compact myocardium of E14.5 mice revealed a 48.5% reduction in Wt1-positive EPDCs in Tbx5 epi-/-hearts versus wild-types ( Figure 3G ). Thus, Tbx5 is important for proper EPDC migration. Migration of EPDCs into the myocardium occurs in a patterned manner that involves several mechanisms, including epicardial cell proliferation, survival, 29, 30 and EMT. 31, 32 Despite the absence of altered proepicardial cell proliferation in E9.5 Tbx5 epi-/-embryos, we observed a 42% reduction in Ki-67-positive proliferating epicardial cells in E12.5 Tbx5 epi-/-embryos ( Figure 4E and 4I) when compared with wild-types ( Figure 4A and 4I). Examination of these hearts for potential EMT defects induced by proepicardial-specific deletion of Tbx5 did not reveal significant changes in the expression of the EMT markers Slug, Snail, and E-cadherin in E14.5 mutant versus wild-type embryos (not shown). These data demonstrate that proepicardial loss of Tbx5 produces developmental defects in the epicardium and EPDCs that may be precipitated by delayed epicardial cell adhesion to the myocardium and partially attributed to a reduction in epicardial cell proliferaton. , 100 μm (A, C, E, G) and 500 μm (B, F, D, H) . Data represented as mean+SEM. *P<0.05 vs wild-type.
Structural Defects and Impaired Cardiac Growth in Tbx5 epi-/-Mice
We did not observe gross morphological differences in whole mount embryos or hearts from E12.5 wild-type and Tbx5 epi-/-mice. Normal formation of the compact myocardium was observed in hematoxylin and eosin-stained wild-type E12.5 hearts ( Figure 4B and 4C) . However, we observed a thinned compact myocardium in E12. epi-/-embryos. However, myocardial apoptosis was observed in E14.5 mutant hearts when compared with wild-types (not shown). In contrast to wild-type hearts ( Figure 4D ), muscular and membranous ventricular septal defects were seen in 15% of E15.5 Tbx5 epi-/-embryos ( Figure 4H ). Collectively, these myocardial defects may result from both a decrease in myocardial cell proliferation and the onset of cardiomyocyte apoptosis secondary to impaired epicardial formation and EPDC development in Tbx5 epi-/-embryos.
Epicardial Inactivation of Tbx5 Affects Development of the EPDCs and Coronary Vasculogenesis
Gross inspection of E15.5 wild-type and Tbx5 epi-/-mice revealed areas of peripheral hemorrhage in mutant embryos (Online Figure VIE) that was not observed in wild-type littermates (Online Figure VIA) . Overall cardiac patterning was similar in both wild-type and mutant mice, but ventricular chamber size appeared to be reduced in Tbx5 epi-/-versus wildtype embryos. In contrast to E15.5 wild-type hearts (Online Figure VIB) , Tbx5 epi-/-hearts exhibited punctate areas of hemorrhaging (Online Figure VIF) . Histology revealed abnormal vascular structures in mutant hearts. As opposed to E15.5 wild-type hearts (Online Figure VIC) , Tbx5 epi-/-hearts exhibited epicardial cyst-like structures lined by delaminated epicardium that were filled with erythrocytes (Online Figure VIG) . Platelet endothelial cell adhesion molecule-1 immunostaining revealed a subepicardial accumulation of vessels in mutant hearts (Online Figure VIH) compared with wild-types (Online Figure VID) . Together, these data are indicative of a coronary vascular defect in Tbx5 epi-/-hearts. Given that EPDCs differentiate into SMCs, cardiac fibroblasts, and endothelial cells, 1,2,7,8 we determined the effects of proepicardial-specific deletion of Tbx5 on these cell populations. Histological analysis of E17.5 wild-type and Tbx5 epi-/-hearts revealed nests of multiple contiguous subepicardial vessel-like structures that did not penetrate the myocardium of mutant hearts ( Figure 5E ) in contrast to wild-type hearts ( Figure 5A ). We determined that SMC recruitment to nascent coronary vessels was affected in Tbx5 epi-/-hearts via immunohistochemical analysis for SMC-specific protein (SM22α). SMCs formed a continuous layer surrounding the coronary vessels of E17.5 wild-type hearts ( Figure 5B ), whereas the SMC layer was either completely lost or discontinuous throughout the coronary vessels of Tbx5 epi-/-hearts ( Figure 5F ). Immunostaining for periostin, a marker of the noncardiomyocyte lineage that is enriched in cardiac fibroblasts, revealed a reduced fibroblast invasion of the cardiac interstitium in E17.5 Tbx5 epi-/-hearts ( Figure 5G ) when compared with wild-types ( Figure 5C ). Platelet endothelial cell adhesion molecule-1 (CD31) immunostaining revealed an elaborate ventricular capillary network in wild-type ( Figure 5D ) and Tbx5 epi-/-hearts ( Figure 5H ). However, subsequent vessel quantification revealed a 45% reduction in platelet endothelial cell adhesion molecule-1-positive capillary density in Tbx5 epi-/-hearts compared with wild-type hearts ( Figure 5M ). Together, these results suggest that a partial defect occurred during coronary vascular maturation in Tbx5 epi-/-hearts that affected SMC recruitment and caused reductions in formation of endothelial cells and other noncardiomyocytes that may include cardiac fibroblasts.
We sought to determine the physiological manifestations of these vascular developmental anomalies. In fact, we observed hypoxia in Tbx5 epi-/-mice. Compared with wild-type hearts ( Figure 5I and 5J), E18.5 Tbx5 epi-/-hearts displayed increased immunoreactivity for hypoxia inducible factor-1α ( Figure 5K ), as well as increased binding of hypoxyprobe-1 (pimonidazole hydrochloride; Figure 5L ), respectively. Hypoxyprobe-1 forms protein adducts in cells with a PO 2 <10 mm Hg. To determine the physiological consequences of this myocardial relative hypoxic state, we evaluated the maximal exercise capacity of Tbx5 epi-/-mice. Twelve-to 16-weekold Tbx5 epi-/-mice were subjected to graded treadmill exercise testing. 33 In contrast to wild-type mice, Tbx5 epi-/-mice exhibited a significantly reduced maximal exercise tolerance ( Figure 5N ).
Transcriptome Analysis of Wild-Type and Tbx5 epi-/-
Mouse Hearts
To gain insight into Tbx5-dependent molecular pathways involved in epicardial and EPDC development during coronary vasculogenesis, we characterized the transcriptome of E11.5 wild-type and Tbx5 epi-/-hearts. Expression of 57 genes was dysregulated in Tbx5 epi-/-hearts (P<0.05). Among these dysregulated genes, 91.2% were downregulated and 8.8% were upregulated in Tbx5 epi-/-versus wild-type hearts ( Figure 6A ). Gene ontology analysis of significantly downregulated transcripts in Tbx5 epi-/-mouse hearts revealed dysregulation of genes involved in vitamin A biosynthesis, cell adhesion, enhancer binding, RNA polymerase II transcriptional activity, and developmental growth ( Figure 6B ). Genes encoding these biological functions, which correlate to retinoic acid signaling, gene transcription, development, and cell-cell interactions, contribute to epicardial and EPDC development. 1, 2, 29, [34] [35] [36] We previously observed focal regions of irregular, ruffled epicardium that were unattached to the myocardium in E11.5 Tbx5 epi-/-hearts, but became attached by E12.5. Because changes in expression of cell adhesion and extracellular matrix (ECM) proteins could contribute to such abnormal epicardial integrity, we used quantitative reverse transcriptase-polymerase chain reaction to validate mRNA expression of the Ajap1, Frem3, and Reln genes encoding these cell adhesion and ECM proteins. [37] [38] [39] Expression of these genes was significantly decreased in epicardial cells and EPDCs of E11.5 mutant versus wild-type hearts ( Figure 6C) October 24, 2014 and this may contribute to the delayed epicardial cell attachment to the myocardium in these hearts.
Discussion
In this study, we demonstrate a conserved requirement for Tbx5 in avian and mammalian proepicardial development, as well as epicardial and coronary vascular formation and maturation. We show that Tbx5 displays a dynamic expression pattern in embryonic proepicardial cell lineages and regulates development of chick and mouse epicardial and coronary vascular progenitor cells from the PEO and epicardium, respectively. Moreover, genetically engineered loss of Tbx5 in the mouse proepicardium results in defective epicardial formation because of delayed epicardial cell adhesion to the myocardium and altered developmental gene expression. We believe that this consequently leads to impaired EPDC production and invasion into the myocardium, compromised establishment of the coronary vasculature, decreased myocardial growth and myocardial hypoxia, and reduced maximal exercise tolerance in Tbx5 epi-/-mice. We conclude that Tbx5 is indispensable for normal epicardial formation and coronary vasculogenesis during embryogenesis, and this requirement may be reflected in the pericardial agenesis and anomalous coronary arteries seen in human patients with HOS and defective TBX5. 19, 20 Loss of murine Tbx5 in the proepicardium did not prevent proepicardial cell specification and formation in Tbx5 epi-/-mouse embryos as exhibited in zebrafish with mutant Tbx5. 40 The genetically heterogeneous nature of the proepicardium was recently demonstrated to have molecularly distinct expression domains 7 and our expression analyses similarly suggest that Tbx5 expression is also heterogeneous throughout the developing proepicardium and epicardium. This may explain the normal specification and development of proepicardial cells in Tbx5 epi-/-embryos. We will further explore this heterogeneity of Tbx5 expression in the proepicardium in future studies. Furthermore, we cannot exclude that other T-box transcription factors expressed in the proepicardium and EPDCs, such as Tbx18 15 , may partially compensate for the Tbx5 deficiency. Although proepicardial development is molecularly conserved across species, 40 we speculate that minor differences in Tbx5 expression and function occur during proepicardial development across species. This was exemplified by the lack of a functionally conserved requirement for Tbx5 between our embryonic chicks and mice in regulating proepicardial cell apoptosis. Although we observed some apoptotic migratory proepicardial cells outside of the TBX5-CXIZ-infected chick PEO explants, we did not observe apoptotic proepicardial cells in Tbx5 epi-/-mouse embryos. We speculate that apoptosis is an epiphenomenon of altered chick Tbx5 gene dose that reflects the untimely fate of proepicardial cells with augmented cell migratory behavior. This may partially explain the reduced incorporation of EPDCs into the coronary vessels of hearts from E15 cTbx5As-CXL or TBX5-CXIZ-injected chick embryos.
The epicardial cell layer formed in E11.5 Tbx5 epi-/-mice. However, its structural integrity appeared defective as exhibited by an irregular, ruffled epicardium with focal regions that delayed attachment to the myocardium until E12.5. Transcriptome analysis of our E11.5 mouse hearts demonstrated that proepicardium-specific deletion of Tbx5 altered several biological functions, including cell-cell interactions. Ajap1, Frem3, and Reln, which encode cell adhesion and ECM proteins, were among the downregulated genes identified in our Tbx5 epi-/-mouse hearts. Epicardial cell adhesion to the myocardium is important for EPDC production and delamination into the subepicardial space, invasion into the myocardium and coronary vasculogenesis. 1, 2, 29, [34] [35] [36] The contribution of these genes to cardiovascular development is unknown, but these structural adhesion molecules are known to mediate cell-cell interactions in extracardiac tissues [37] [38] [39] and, thus, we have identified novel genes involved in a Tbx5-dependent pathway of epicardial development. We think that downregulation of these cell adhesion and ECM genes may contribute to the delayed epicardial cell attachment to the myocardium in Tbx5 epi-/-hearts. Proper establishment of epicardial structure provides the foundation for subsequent EPDC development, delamination into the subepicardial space and myocardial invasion to form coronary vessels. Thus, it is likely that the defective epicardial structure of our Tbx5 epi-/-embryonic hearts precipitated the decrease in EPDC production, impaired myocardial migration of EPDCs, and also perturbed coronary vasculogenesis. These findings are reminiscent of the structural and functional defects observed during epicardium and coronary vascular development of proepicardium-specific Tbx18-deficient mice, which similarly exhibited an irregular epicardial surface with frequent areas distended from the myocardium, as well as subepicardial nodules containing erythroblasts. 15 EPDC invasion of the myocardium involves several mechanisms, including epicardial cell proliferation, survival, 29, 30 and EMT. 31, 32 Although expression of EMT and apoptotic markers was unaffected by proepicardium-specific deletion of Tbx5 in our mice, epicardial cell proliferation was significantly reduced in E12. 5 Tbx5 epi-/-embryos. Tbx5 has been previously shown to regulate cell proliferation during morphogenesis of tissues, including the vertebrate heart. 27, 41 The diminished epicardial cell proliferation observed in our mutant mice may underlie the impaired production of EPDCs given that epicardial cell proliferation is intricately linked to EPDC invasion of the myocardium. 30, 42 Thus, we think that the impaired EPDC development in our Tbx5 epi-/-embryos is a consequence of a suboptimal environment previously established by delayed epicardial cell adhesion to the myocardium and this is compounded by reduced epicardial cell proliferation. The resultant inability of EPDCs to invade the myocardium is consistent with previous reports of altered deposition of adhesion molecules during mammalian cardiogenesis that hindered EPDC migration into the ventricular myocardium. 29, 34, 43, 44 Altogether, these data indicate that Tbx5 expression is critical for establishing normal epicardial structure and subsequent EPDC production.
EPDCs contribute to the formation of SMCs, endothelial cells, and cardiac fibroblasts in avian and murine hearts during coronary vasculogenesis. 1, 2, 7, 45 In fetal Tbx5 epi-/-mouse hearts, we observed impaired SMC recruitment and a reduction in endothelial cells and cardiac fibroblasts. Our data demonstrate that impaired development of these lineages subsequently leads to abnormal coronary vasculogenesis in Tbx5 epi-/-hearts. Further analysis will need to be performed to determine whether Tbx5 acts directly or indirectly to influence differentiation of these lineages. However, we speculate that delayed epicardial cell attachment to the myocardium precipitates a cascade of events that lead to abnormal coronary vasculogenesis in Tbx5 epi-/-hearts. Our data collectively support a model in which proepicardium-specific Tbx5 deficiency inhibits expression of cell adhesion and ECM proteins and delays epicardial cell attachment to the myocardium to disrupt epicardium integrity. The epicardium defect is made worse by reduced epicardial cell proliferation. As a result, EPDC production, delamination into the subepicardial space, and myocardial invasion are impaired. Together, these events contribute to abnormal coronary vasculogenesis in Tbx5 epi-/-embryos. In addition, Tbx5 epi-/-mice exhibit hypoplastic ventricular trabeculation and 15% of mice display ventricular septal defects consistent with paracrine effects of the epicardium on stimulating myocardial growth and development. To our knowledge, Tbx5 epi-/-mice represent the first proepicardium-specific deletion mouse model to exhibit cardiac septation defects. Atrial septal defects caused by apoptosis or reduced cell proliferation were previously observed on Tbx5 deletion in the endocardium 46 or posterior second heart field, 41 respectively. Therefore, it is plausible that EPDCs display similar non cell-autonomous growth-promoting activities on the interventricular septum. In addition, our analysis of Wt1 expression in the developing mouse heart documented the presence of Wt1-positive EPDCs in the interventricular septum, and reports have raised the possibility that EPDCs may differentiate into cardiomyocytes in the interventricular septum. 1, 8 Thus, septation defects observed in mice with ubiquitous Tbx5 deficiency and in patients with HOS may result from reduced Tbx5 activity in the myocardium, as well as in the proepicardium and epicardium. [19] [20] [21] Proepicardial-specific loss of Tbx5 in mice causes embryonic lethality that may result from cumulative effects on coronary vasculogenesis and epicardial cell growth and survival to, subsequently, impose myocardial growth defects that alter cardiac structure. Defective coronary vasculogenesis leads to ischemic cardiomyopathy in adult Tbx5 epi-/-mice. These mice exhibit resting hypoxia and exercise-induced ischemia. It is not uncommon for human adults to present with poorly explained cardiomyopathy long after childhood repair of congenital heart malformations, and patients with HOS have been reported to develop diastolic ventricular dysfunction even after repair of septation defects. 47 Ischemia is a well-recognized cause of reduced ventricular compliance, and thus subclinical microvascular hypoplasia in HOS may contribute to chronic ischemia and the late onset cardiomyopathy that has been observed. On the basis of our observations that augmentation of chick and murine Tbx5 affects proepicardial development, disrupts epicardial structural integrity, impairs EPDC development, and decreases vascular investment of the myocardium, we conclude that Tbx5 is indispensable for normal epicardial and coronary vascular formation during embryogenesis. This requirement for Tbx5 in mouse and chick epicardial development may be reflected in the pericardial agenesis and anomalous coronary arteries seen in human patients with HOS and defective TBX5. 19, 20 Additional studies will determine the combined effects of epicardial and myocardial Tbx5 activity to dissect pathways in normal cardiogenesis and the phenotypes of patients with HOS.
• The proepicardial organ/proepicardium is a grape-like structure located caudal to the heart that contributes precursor cells during cardiovascular development to form the epicardium, pericardium, coronary vessels, and cardiac fibroblasts through a series of coordinated events involving regulation of gene expression and cell behavior.
• During cardiovascular development, Tbx5 mRNA is detected in the embryonic chick proepicardial organ, and TBX5 protein is expressed in the epicardium and coronary vessels of the fetal human heart. • TBX5 overexpression in the proepicardial organ disrupts proepicardial cell migration to the coronary vasculature in the embryonic chick heart, whereas loss of Tbx5 in the developing zebrafish heart leads to the absence of proepicardium formation.
What New Information Does This Article Contribute?
• We developed strategies to investigate Tbx5 activity in formation and maturation of the epicardium and coronary vessels through retroviralmediated transgenesis in the embryonic chick and tissue-specific deletion of Tbx5 in the developing mouse proepicardium.
• Our findings reveal that proepicardium -specific loss of mouse Tbx5 causes delayed epicardial attachment to the myocardium and subepicardial accumulation of epicardial-derived cells that, we believe, precipitates a cascade of events to impair epicardial maturation and formation of the coronary vasculature, inhibit cardiac growth, and elicit myocardial hypoxia in the mammalian heart. • Tbx5 is indispensable for normal epicardial formation and coronary vasculogenesis during embryogenesis and this may be reflected by the pericardial agenesis and anomalous coronary arteries seen in some human patients with Holt-Oram syndrome and TBX5 mutations.
Previous studies identified Tbx5 roles in myocardial, endocardial, and cardiac conduction system development. However, potential Tbx5 activity in the epicardium and mammalian coronary vasculogenesis remains unidentified. We show that Tbx5 expression in the proepicardium and epicardium is heterogeneous. Our augmentation of Tbx5 expression in embryonic chick proepicardial organ and epicardium reveals its requirement in proepicardial cell migration for formation and maturation of the epicardium and incorporation of epicardial-derived cells into coronary blood vessels. Mice genetically engineered for proepicardial-specific Tbx5 loss (Tbx5
epi-/-
) are born at sub-Mendelian ratios. Although the proepicardium forms properly in these mice and proepicardial cells begin migration toward the myocardium at embryonic day (E)10.5, Tbx5 deficiency delays epicardial cell attachment to the E11.5 myocardium. Cell adhesion and extracellular matrix gene expression are reduced in E11.5 Tbx5 epi-/-hearts. Although epicardial cells attach to myocardium by E12.5, Tbx5 epi-/-embryos exhibit other defects, including impaired epicardial-derived cell production and invasion into the myocardium, compromised establishment of coronary vessels, decreased myocardial growth and myocardial hypoxia. Adult Tbx5 epi-/-mice are intolerant to exercise. We conclude that Tbx5 is required in normal epicardial formation and coronary vasculogenesis. This requirement provides insight into pericardial agenesis and anomalous coronary arteries observed in patients with HOS and TBX5 mutations.
